A Study to Evaluate Safety, Engraftment, and Efficacy of VC-01 in Subjects With T1 Diabetes Mellitus

Summary

VC01-103 will evaluate an experimental combination product, cell replacement therapy intended to provide a functional cure to subjects with Type 1 Diabetes.

Timeline

Start

2019-06-25

Primary completion

2021-11-12

Completion

2021-11-19

Outcome

Outcome not reported

Stopped: “Insufficient functional product engraftment”

Drugs

Indications